Detection of the antibacterial role of Achillea millefolium against Escherichia coli isolated from urinary tract infections
Abstract
Despite the fact that the pharmaceutical industry has developed numerous novel antibiotics over the last three decades, bacteria have developed resistance to these medications. Bacteria have the genetic potential to transfer and develop resistance to medications used as therapeutic agents. Therefore, the present study aimed to reveal the antibacterial role of Achillea millefolium against Escherichia coli isolated from urinary tract infections. Between February and July of 2024, 130 clinical samples were taken from individuals who were admitted to Kirkuk Hospital in Kirkuk City after visiting a specialist and being sent to the laboratory. Urine samples were taken from patients with UTI ranging in age from (1-60 years) of women, after which they were transferred directly to the laboratory to be cultured on the culture media, then A. millefolium extract was tested against Escherichia coli, compared with some standard antibiotics. Results showed that 57 (43.8%) of the total samples showed positive results for bacterial growth when cultured on the best culture media, which included blood and MacConkey agars. 73 (or 56.2%) of the total samples had results that showed no bacterial growth. E. coli showed total resistance (100%) to Ampicillin. While, a low sensitive toward Nalidixic acid (20.0%), Clindamycin (20.0%) 21.5%. Otherwise, E. coli showed a high sensitive to Gentamycin (87.7%), Imipenem (96.9%), and Amikacin (90.8%). While Tobromycin showed high sensitive 100.0%…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.